Cargando…
Novel dimeric DOTA-coupled peptidic Y(1)-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers
BACKGROUND: Several peptide hormone receptors were identified that are specifically over-expressed on the cell surface of certain human tumors. For example, high incidence and density of the Y(1 )subtype of neuropeptide Y (NPY) receptors are found in breast tumors. Recently, we demonstrated that the...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250963/ https://www.ncbi.nlm.nih.gov/pubmed/22214201 http://dx.doi.org/10.1186/2191-219X-1-21 |